Comera Life Sciences
(OTC) CMRA
Comera Life Sciences Financials at a Glance
Market Cap
$3,100
Revenue (TTM)
$1.00M
Net Income (TTM)
$9.01M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
2999.08 (High)
Dividend
$0.00
Beta (Volatility)
2999.08 (High)
Price
$0.00
Volume
1,875
Open
$0.00
Price
$0.00
Volume
1,875
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
2999.08 (High)
Price
$0.00
Volume
1,875
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
CMRA News
CMRA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Comera Life Sciences
Industry
Biotechnology
Sector
Health CareEmployees
13
CEO
Jeffrey S Hackman
Website
comeralifesciences.comHeadquarters
Woburn, MA 01801, US
CMRA Financials
Key Financial Metrics (TTM)
Gross Margin
67%
Operating Margin
-19%
Net Income Margin
-28%
Return on Equity
0%
Return on Capital
9%
Return on Assets
-5%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.10K
Shares Outstanding
30.74M
Volume
1.88K
Short Interest
0.00%
Avg. Volume
311.25
Financials (TTM)
Gross Profit
$422.71K
Operating Income
$11.97M
EBITDA
$17.89M
Operating Cash Flow
$9.77M
Capital Expenditure
$28.61K
Free Cash Flow
$9.80M
Cash & ST Invst.
$446.61K
Total Debt
$775.05K
Comera Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$136.31K
-42.0%
Gross Profit
$94.35K
-45.8%
Gross Margin
69.22%
N/A
Market Cap
$3.10K
N/A
Market Cap/Employee
$258.33
N/A
Employees
12
N/A
Net Income
$2.15M
+30.0%
EBITDA
$2.12M
+30.1%
Quarterly Fundamentals
Net Cash
$1.60M
+14.7%
Accounts Receivable
$100.00K
-66.0%
Inventory
$0.00
-100.0%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$171.60K
-84.5%
Return on Assets
-4.83%
N/A
Return on Invested Capital
8.99%
N/A
Free Cash Flow
$1.91M
+20.7%
Operating Cash Flow
$1.91M
+19.9%